Who is sponsoring NCT04927078?

NCT04927078 is sponsored by Oxehealth Limited.

What drugs are being tested in NCT04927078?

Interventions in NCT04927078: Observation of breathing pattern.

What condition does NCT04927078 study?

NCT04927078 studies Respiratory Disease.

Is NCT04927078 still recruiting?

NCT04927078 is currently completed. Last updated 15 June 2021.

Last reviewed 2021-06-15 · How we verify

NCT04927078

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Analysis of Vital Signs in Patients With COVID-19

Completed Last updated 15 June 2021

What this trial tests

trial testing Observation of breathing pattern in Respiratory Disease in 20 participants. Completed in 31 October 2020.

Timeline

1 April 2020

Primary endpoint
31 October 2020

31 October 2020

Quick facts

Lead sponsor	Oxehealth Limited
Status	Completed
Study type	OBSERVATIONAL
Enrollment	20
Start date	1 April 2020
Primary completion	31 October 2020
Estimated completion	31 October 2020
Sites	1 location across United Kingdom

Drugs / interventions tested

Observation of breathing pattern

Conditions studied

Respiratory Disease — all drugs for Respiratory Disease →

Sponsor

Oxehealth Limited

Who can join

18 and older, any sex, with Respiratory Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will use data obtained from a proprietary vision-based patient monitoring and management system (OxeVision) for measuring heart rate and respiratory rate which is in clinical use at the Coventry and Warwickshire Partnership NHS Trust.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Respiratory Disease

Currently open trials in the same condition.

NCT06716502 — A New Portable Device for Non-invasive Ventilatory Support · NA · recruiting
NCT06455033 — Manual Diaphragm Release on Stepping Reaction Time in Chronic Obstructive Pulmonary Disease · NA · active not recruiting
NCT06796894 — Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics · recruiting
NCT06503913 — Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder · NA · active not recruiting
NCT06569940 — Sleepiz One+ vs. Capnography and Electrocardiography · NA · recruiting

Other Oxehealth Limited trials

Trials by the same sponsor.

NCT05013411 — Rethinking Observations in Mental Health · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04927078 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oxehealth Limited
Last refreshed: 15 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04927078.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing